These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18788990)

  • 1. Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    J Womens Health (Larchmt); 2008 Oct; 17(8):1363-9. PubMed ID: 18788990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial.
    Choquette S; Riesco É; Cormier É; Dion T; Aubertin-Leheudre M; Dionne IJ
    Br J Nutr; 2011 Apr; 105(8):1199-209. PubMed ID: 21205384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women.
    Goodman-Gruen D; Kritz-Silverstein D
    J Nutr; 2001 Apr; 131(4):1202-6. PubMed ID: 11285326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoglycemic effects of soy isoflavones on postmenopausal women.
    Cheng SY; Shaw NS; Tsai KS; Chen CY
    J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
    Ho SC; Chen YM; Ho SS; Woo JL
    Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of isoflavones and exercise training on inflammatory cytokines and body composition in overweight and obese postmenopausal women: a randomized controlled trial.
    Lebon J; Riesco E; Tessier D; Dionne IJ
    Menopause; 2014 Aug; 21(8):869-75. PubMed ID: 24378766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women.
    Garrido A; De la Maza MP; Hirsch S; Valladares L
    Maturitas; 2006 Jun; 54(3):270-6. PubMed ID: 16414215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women.
    Aubertin-Leheudre M; Lord C; Goulet ED; Khalil A; Dionne IJ
    Obesity (Silver Spring); 2006 Dec; 14(12):2277-83. PubMed ID: 17189556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study.
    Hidalgo LA; Chedraui PA; Morocho N; Ross S; San Miguel G
    Gynecol Endocrinol; 2005 Nov; 21(5):257-64. PubMed ID: 16373244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.
    Atteritano M; Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Mazzaferro S; D'Anna R; Cannata ML; Gaudio A; Frisina A; Frisina N; Corrado F; Cancellieri F; Lubrano C; Bonaiuto M; Adamo EB; Squadrito F
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3068-75. PubMed ID: 17682090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM
    Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial.
    Ye YB; Wang ZL; Zhuo SY; Lu W; Liao HF; Verbruggen M; Fang S; Mai HY; Chen YM; Su YX
    Menopause; 2012 Jul; 19(7):791-8. PubMed ID: 22278344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial.
    Wu J; Oka J; Tabata I; Higuchi M; Toda T; Fuku N; Ezaki J; Sugiyama F; Uchiyama S; Yamada K; Ishimi Y
    J Bone Miner Res; 2006 May; 21(5):780-9. PubMed ID: 16734394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women.
    Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
    Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study.
    Campbell MJ; Woodside JV; Honour JW; Morton MS; Leathem AJ
    Eur J Clin Nutr; 2004 Jan; 58(1):173-9. PubMed ID: 14679383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.
    Jayagopal V; Albertazzi P; Kilpatrick ES; Howarth EM; Jennings PE; Hepburn DA; Atkin SL
    Diabetes Care; 2002 Oct; 25(10):1709-14. PubMed ID: 12351466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial.
    Curtis PJ; Sampson M; Potter J; Dhatariya K; Kroon PA; Cassidy A
    Diabetes Care; 2012 Feb; 35(2):226-32. PubMed ID: 22250063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: a 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes.
    Liu ZM; Chen YM; Ho SC; Ho YP; Woo J
    Am J Clin Nutr; 2010 May; 91(5):1394-401. PubMed ID: 20335543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.